Laboratorios Farmacéuticos ROVI, S.A. S.A. is a fully-integrated, profitable, Spanish specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of small molecule and specialty biologic drugs.

Laboratorios Farmacéuticos ROVI, S.A. in line with its commitment to transparency and informative rigour presents this web section addressed to shareholders and investors, with the purpose to make available all information required by the ministerial decree ECC/461/2013 of March 20 and the Circular 3/2015 of June 23 of the CNMV, as well as all information available that the company will consider relevant about Corporate Governance's practices.


DateTitleContent
26/07/2017Información sobre resultadosROVI releases the presentation related to the 2017 first half results
26/07/2017Información sobre resultadosROVI releases the presentation related to the 2017 first half results
25/07/2017Otros sobre Gobierno CorporativoThe Company informes about the modification of the Internal code of conduct
10/07/2017Contratos de liquidez y contrapartidaThe Company informs that has cancelled the liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U.
10/07/2017Contratos de liquidez y contrapartidaThe Company informs that has signed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U.